What is the current stock price of Immunovia AB (publ) (IMMVF)?

As of the latest market data, Immunovia AB (publ) (IMMVF) is trading at $0.02. The stock has seen a loss of 0.00% today.

Does Immunovia AB (publ) (IMMVF) pay a dividend?

Based on current data, Immunovia AB (publ) does not have a confirmed active dividend policy.

What is the market cap of Immunovia AB (publ)?

The current market capitalization of Immunovia AB (publ) (IMMVF) is approximately unavailable.

IMMVF

Immunovia AB (publ)·Healthcare

0.02

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0252W H: $0.15

IMMVF NEWS

seekingalpha.com

Feb 24

Immunovia AB (publ) (IMMVF) Q4 2025 Earnings Call Transcript

Company Profile

Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

IPO Date

2019-06-28

Beta

2.63

Websitewww.immunovia.com↗